Navigation Links
Agent orange chemical, dioxin, attacks the mitochondria to cause cancer, says Penn research team
Date:12/17/2007

PHILADELPHIA Researchers with the University of Pennsylvania School of Veterinary Medicine have demonstrated the process by which the cancer-causing chemical dioxin attacks the cellular machinery, disrupts normal cellular function and ultimately promotes tumor progression.

The team identified for the first time that mitochondria, the cellular sub-units that convert oxygen and nutrients into cellular fuel, are the target of tetrachlorodibenzodioxin, or TCDD. The study showed that TCDD induces mitochondria-to-nucleus stress signaling, which in turn induces the expression of cell nucleus genes associated with tumor promotion and metastasis.

The mechanism the research team has described is directly relevant to understanding incidences of breast and other cancers in human populations exposed to these chemicals. With a better understanding of this underlying cellular mechanism, researchers hope to improve their understanding of tumor growth and promotion.

"Now that we have identified this signaling mechanism we can look at ways to disrupt this complex chain of events, said Narayah Avadhani, chair of the Department of Animal Biology at Penns School of Veterinary Medicine and the studys lead investigator. Our ultimate goal is to block the propagation of this mitochondrial stress signaling and inhibit the expression of the proteins that combine to assist cancer growth.

A well-characterized mechanism of TCDD action occurs through activation of arylhydrocarbon receptors, AhR, by directly binding to the protein subunits. Activated AhR mediates the transcriptional activation of many genes including those involved in fatty acid metabolism, cell cycle regulation and immune response. The present study, however, shows that TCDD starts the chain of events that promote tumor progression in vivo by directly targeting mitochondrial transcription and induction of mitochondrial stress signaling. A unique feature of this TCDD-induced signaling i
'/>"/>

Contact: Jordan Reese
jreese@upenn.edu
215-573-6604
University of Pennsylvania
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
2. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
3. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
4. MassMutual Agent Honored by Insurance Industry for Extraordinary Service to Client
5. Sagent Pharmaceuticals Inc. Completes $53 Million Series A Financing
6. ABR-Affinity BioReagents Expands 100% Quality Guarantee
7. Inside job: new radioactive agents for colon cancer work inside cells
8. ABR -- Affinity BioReagents Announces Launch of New Website
9. The Bank of New York Mellon Recognized as Change Agent Shaping the Direction of Healthcare Transaction Processing
10. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
11. Imagentix Offers Extension of Warrants

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/10/2009)...New Tools for Sharing and Advancing Medical Knowle...PRWEB) November 10, 2009 -- The Medpedia Project t...on the beta version of the technology platform for...for asking and answering medical and health questi...cal and health news alerts; and Medpedia News &...
(Date:11/10/2009)...It is now possible to achieve exceptionally smooth...f hard materials such as ceramics, carbide and har... new Diamond Flex-Hone® honing tool from Bru... Los Angeles (PRWEB) November 10, 2009 -- Using ex... to the ends of flexible filaments, the Diamond Fl...
(Date:11/10/2009)...Internationally recognized child and family therap... exclusive line of resources on healthy newborn at...ustries, LLC., makers of the world-famous swadder ...st Miracle Parenting™, will offer a valuable... a couple thousand independent retail shops alongs...
(Date:11/9/2009)...Tarkett Sports, the worldwide leader in sports sur... offering with a more complete and innovative rang... sports flooring experts and the launch of www.ta... (PRWEB) November 9, 2009 -- Tarkett Sports, redes...g products includes hardwood and synthetic basketb...
(Date:11/9/2009)...ss Month Highlighted During Broadcast ,, WASHI...er Alliance (LCA) announced that LCA staff, advoca... New York Stock Exchange(TM) (NYSE) tomorrow after...om.com/cgi-bin/prnh/20081016/LCALOGO ) ,, Five...dvocate, Richard Heimler will mark the end of the ...
Breaking Medicine News(10 mins):Health News:Medpedia Project Expands Platform to Include Q&A, News & Analysis and Alerts 2Health News:Medpedia Project Expands Platform to Include Q&A, News & Analysis and Alerts 3Health News:Medpedia Project Expands Platform to Include Q&A, News & Analysis and Alerts 4Health News:Diamond Honing Tool Technology: The New Standard in Surface Finishing of Hard Materials 2Health News:Attachment & Emotional Development Expert Teams Up with Miracle Industries, LLC. to Launch Valuable Parenting Resource 2Health News:Attachment & Emotional Development Expert Teams Up with Miracle Industries, LLC. to Launch Valuable Parenting Resource 3Health News:Attachment & Emotional Development Expert Teams Up with Miracle Industries, LLC. to Launch Valuable Parenting Resource 4Health News:Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website 2Health News:Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange(TM) 2
...st common in-flight medical emergency. Research re...ournal Critical Care details the number, type an...rlines. , Michael Sand led a team of researchers ...ough in-flight medical emergencies are rare in gen...
...mily Faces Same Decision as Millions: How to Care ...le Obama,s mother, Marian Robinson, moves into the...prightly mother, Jean, is in for some life changes... Washington, D.C. to take on the demanding job of ...
..., Week to be observed Jan. 25 - 31 , , HARRIS...have made quitting smoking a personal goal for 200... limited number of free nicotine replacement thera... before being successful, and those who have suppo...
...alian and international scientists will gather in ...Neuroscience Society (ANS) meeting. It marks a hom...a meeting in Canberra in 1980, with substantial in...e, revealing the latest discoveries in brain and n...
...DON, Jan. 23 Schofield Healthcare Media Ltd,(SHML...nced on the 16th,January that it has acquired Medi... set up by Jane Jones in 1997 as the publishing an...alising in effective,targeted and intelligent medi...
...ar 2008 Revenue of Approximately $250 Million , ,... Million to $350 Million , , SAN DIEGO, Jan. 23 ... company focused on developing products for minima...d provided financial guidance for the full year 20...
Other Medicine News:Health News:Research identifies in-flight emergencies 2Health News:Change for the Country = Change for the Bidens 2Health News:Change for the Country = Change for the Bidens 3Health News:Pennsylvania to Offer Free Nicotine Replacement Therapy Kits Beginning Feb. 2 2Health News:The world's best brains descend on Canberra 2Health News:Further Acquisition for (London Based) Schofield Healthcare Media 2Health News:NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results 2Health News:NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results 3Health News:NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results 4
(Date:11/9/2009).../ -- Volcano Corporation (Nasdaq: VOLC ), a leade...ducts for the diagnosis and treatment of coronary ...will be participating in the Third Annual Canaccor...0. ,, The presentation by Scott Huennekens, pre...1 p.m., Pacific Standard Time (4 p.m., Eastern Sta...
(Date:11/9/2009)...tCall/ -- Cardiac Science Corporation (Nasdaq:...fibrillator ( AED ) and diagnostic cardiac monit...llion for the third quarter ended September 30, 20...y also recorded a charge of $18.5 million for an A...44.0 million to increase its valuation allowance a...
(Date:11/9/2009)...Call/ -- Boston Scientific Corporation (NYSE: BSX...8th annual Global Congress for Minimally Invasive ...in Orlando, Florida. Results from two clinical st...ology/Gynecology products, including pelvic floor ...ems used to treat pelvic floor vaginal wall prolap...
Breaking Medicine Technology:Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5New research 3A Consumption of sugar substitutes assists in long term weight control 55125 1New research 3A Consumption of sugar substitutes assists in long term weight control 55125 2When cells run out of fuel 9677 1When cells run out of fuel 9677 2Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 1Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 2Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 3
...07 - Hemispherx Biopharma,Inc. (AMEX: HEB) announ...l of Immunology, April 2007) that explains the uni...rimental therapeutic,Ampligen(R) (Poly I : Poly C...notherapy for Chronic Fatigue Syndrome and as an,a...-reviewed study shows conclusively that the biolog...
...frontera AG announced,that an interim report regar...eratosis was received today from an independent re... investigate the,efficacy and safety of several do...ments received today refer to the clinical results... about the results,after twelve weeks will follow....
Other Medicine Technology:New Report Illuminates Ampligen's Unique Mechanism of Action 2New Report Illuminates Ampligen's Unique Mechanism of Action 3New Report Illuminates Ampligen's Unique Mechanism of Action 4
Nova Epi-fluorescence
...are the hallmark of these stereozoom fluorescent m...n mind. The top (incident) circular 9W fluorescent...inating shadows while remaining cool to the touch....e with 10x to 44x zoom magnification or high-power...
...vative and efficient inverted routine microscope. ...cility. Improved mechanics and increased stability...cular and TS100-F trinocular models. The TS100-F t...ts Nikon's FX-III series photomicrographic systems...
...system utilizes an evanescent wave to excite singl...e coverglass. Extendable "stratum structure". This...th TIRF and epi-fluorescence illumination systems,...ies. It also allows their dedicated filters to be ...
Medicine Products: